Crohn's disease phenotype, prognosis, and long-term complications : what to expect ?

被引:0
|
作者
Cosnes, Jacques [1 ,2 ]
机构
[1] Hop St Antoine, Serv Gastroenterol & Nutr, F-75571 Paris, France
[2] Univ Paris 06, Paris, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
According to Montreal classification, different phenotypes of Crohn's disease are defined taking into account age at diagnosis, localization of digestive lesions at first surgery, and cumulative anatomical behaviour. This classification is supported by the increased severity of the disease when diagnosed in childhood, the relative stability of disease localization over time, and the clinical importance of intestinal complications as stricture and abscess or fistula formation. However, type and delay of complications are dependent on disease localization (they develop early in small bowel disease and late in colitis), every patient will develop complications one day, and perianal disease may be an important problem observed in up to half the patients. The percentage of patients with active disease every year remains stable, about 40%, after the 3 first years, and only a few patients have long periods of remission. Intestinal resections are required in the majority of patients during life, and many are operated on several times. Prognosis is hampered by iterative surgery, cancer and side-effects of treatment. Standardized mortality ratio is 1.50. Although occurrence of complications, need for surgery and mortality did not change significantly through the years 1950-2000, there are some signals suggesting that new therapetic strategies (immunosuppressants earlier in high risk patients) and biologics will modify natural history and improve the long term prognosis. (Acta gastroenterol. belg., 2008, 71, 303-307).
引用
收藏
页码:303 / 307
页数:5
相关论文
共 50 条
  • [41] Long-term outcomes of thalidomide in pediatric Crohn's disease
    Wang, Lin
    Xue, Aijuan
    Zheng, Cuifang
    Zhou, Ying
    Wang, Yuhuan
    Huang, Ying
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (07) : 1124 - 1129
  • [42] Infliximab in Crohn's disease: early and long-term treatment
    Armuzzi, A.
    De Pascalis, B.
    Fedeli, P.
    De Vincentis, F.
    Gasbarrini, A.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S271 - S279
  • [43] Methotrexate in Crohn's disease:: long-term efficacy and toxicity
    Lémann, M
    Zenjari, T
    Bouhnik, Y
    Cosnes, J
    Mesnard, B
    Rambaud, JC
    Modigliani, R
    Cortot, A
    Colombel, JF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (07): : 1730 - 1734
  • [44] Long-term evolution of oral localization of Crohn's disease
    Cosnes, A
    Dupuy, A
    Revuz, J
    Delchier, JC
    Contou, JF
    Gendre, JP
    Cosnes, J
    GASTROENTEROLOGY, 1998, 114 (04) : A956 - A956
  • [45] Strictureplasty for Crohn’s Disease: Techniques and Long-term Results
    Roger D. Hurst
    Fabrizio Michelassi
    World Journal of Surgery, 1998, 22 : 359 - 363
  • [46] LONG-TERM RESULTS IN SURGICAL TREATMENT OF CROHN'S DISEASE
    杜如昱
    李树铎
    黄萃庭
    郭钤新
    施维明
    中华医学杂志(英文版), 1984, (05) : 317 - 321
  • [47] EFFICACY AND SAFETY OF INFLIXIMAB IN THE LONG-TERM IN CROHN'S DISEASE
    Fries, W.
    Privitera, A. C.
    Lo Presti, M. A.
    Mastronardi, M.
    Cappello, M.
    Grossi, L.
    Lauria, A.
    Principi, M.
    Della Valle, N.
    Buccianti, N.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S134 - S134
  • [48] Long-term fate of the excluded rectum in Crohn's disease
    Yzet, C.
    Kassim, G.
    Nair, N.
    Colombel, J. -F.
    Sachar, D. B.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S258 - S258
  • [49] Long-term durability of Crohn's disease treatment with infliximab
    Rudolph, Stephen J.
    Weinberg, David I.
    McCabe, Robert P.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (04) : 1033 - 1041
  • [50] Long-term outcomes of thalidomide in refractory Crohn's disease
    Gerich, M. E.
    Yoon, J. L.
    Targan, S. R.
    Ippoliti, A. F.
    Vasiliauskas, E. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (05) : 429 - 437